Table 5.
Comparison of maternal safety and perinatal complications between Two groups.
| Indicator (measurement/definition) | Combined group (n = 60) | Control group (n = 60) | Test statistic | P value |
|---|---|---|---|---|
| Postpartum blood loss (mL, mean ± SD) | 358 ± 130 | 345 ± 120 | t = 0.569 | 0.570 |
| Postpartum hemorrhage (>1,000 mL), n (%) | 1 (1.7%) | 2 (3.3%) | —— | 1.000 |
| Transfusion rate, n (%) | 1 (1.7%) | 2 (3.3%) | —— | 1.000 |
| Transient hypotension, n (%) | 3 (5.0%) | 4 (6.7%) | —— | 1.000 |
| Nausea/vomiting, n (%) | 4 (6.7%) | 5 (8.3%) | —— | 1.000 |
| Uterine hyperstimulation, n (%) | 1 (1.7%) | 0 (0%) | —— | 1.000 |
| Epidural-related complications | ||||
| Post-dural puncture headache (PDPH), n (%) | 1 (1.7%) | 1 (1.7%) | —— | 1.000 |
| Epidural puncture site infection, n (%) | 0 (0%) | 0 (0%) | —— | —— |
| Epidural hematoma, n (%) | 0 (0%) | 0 (0%) | —— | —— |
| Other adverse events requiring medical intervention (description), n (%) | 1 (1.7%) (transient altered consciousness, recovered after observation) | 1 (1.7%) (transient tachycardia, recovered after monitoring) | —— | 1.000 |
| Composite adverse events (any of the above maternal adverse events), n (%) | 5 (8.3%) | 6 (10.0%) | χ2 = 0.100 | 0.751 |
| Length of hospital stay (days, mean ± SD) | 3.2 ± 0.9 | 3.8 ± 1.0 | t = −3.45 | 0.001 |
“—” indicates not applicable or not observed.